Hillevax
1 follower
HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Their initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infecti... Read more
Org chart
Rob Hershberg
CEO, President & Chair
Rob Hershberg
Collapse
Aditya Kohli
COO
Shane Maltbie
Chief Financial Officer
Astrid Borkowski
Chief Medical Officer
Paul Bavier
General Counsel, Secretary & Chief Administrative Officer
Tomoe Felder
Director, Strategy And Operations, Chief Medical Office
Ozzie Berger
Senior Vice President
Christopher Aakre, PhD
Vice President, Program Management
Holger Koch
VP Analytical Research & Development
Shannon Harris
Vice President, Head Of Clinical Assays
Steven Hauser
Vice President Of Manufacturing
Tara Raab
Vice President Of Quality
Anju Chatterji
Chief Technology Officer
Yang Wang MD, PhD
Vice President, Research And Preclinical Development
Wendy T.
VP, Head of Clinical Operations
